 | | Vol. 15.33 – 24 August, 2023 |
| |
|
|
| Researchers discovered that apoptotic body-null MRL/lpr mice showed resistance to breast cancer cell implantation, with more CD8+ T cell infiltrations and a higher survival rate.
[Cell Reports Medicine] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators confirmed upregulated NORAD expression levels in a set of human epithelial breast cancer cell lines, which belong to the most aggressive subtypes
[Molecular Therapy – Nucleic Acids] |
|
|
|
| Scientists explored the effects of fibroblast growth factor 1 (FGF1) on estrogen receptor (ER)-positive endocrine-sensitive and resistant breast cancer and compared that to the effects of the canonical ER ligand, estradiol.
[Breast Cancer Research] |
|
|
|
| Researchers showed that one lead peptide Tat-SP4 induced mild increase of autophagy in TNBC cells but showed potent anti-proliferative effect that could not be rescued by inhibitors of programmed cell death pathways.
[Cell Death Discovery] |
|
|
|
| The authors used 1H-NMR metabolomics to study the effects of AA9, a novel TG2 inhibitor, on two breast cancer cell lines with distinct phenotypes, MCF-7 and MDA-MB-231.
[FEBS Journal] |
|
|
|
| Investigators verified whether acid ground nano-realgar processed product induced breast cancer mitophagy and explored the mitophagy-mediated mechanism.
[Journal of Cellular and Molecular Medicine] |
|
|
|
| Scientists reported two novel miRNAs within intron 4 of Musashi1, MSI1, gene named MSM2 and MSM3, which were selected among several miRNA precursors predicted by bioinformatic studies.
[Scientific Reports] |
|
|
|
| Researchers investigated the role and mechanism of LncRNA Miat knockdown in improving pirarubicin (THP) sensitivity. They assessed the role of Miat overexpression/knockdown on THP-mediated 4T1 anticancer activity
[Environmental Toxicology] |
|
|
|
| The authors investigated the effects of exposure to low-power lasers and LEDs on cell viability, migration, and invasion in human breast cancer cells.
[Lasers in Medical Science] |
|
|
|
|
| Scientists discuss the role of lncRNAs in regulation of PI3K/AKT, MAPK, and TGF-β signaling pathways in breast tumor cells.
[Journal of Translational Medicine] |
|
|
|
|
| The Biden Cancer Moonshot is announcing the launch of “Curing the Uncurable via RNA-Encoded Immunogene Tuning” (CUREIT), a project that aims to develop generalizable mRNA platforms that can be harnessed to train the immune system to more effectively fight cancer and other diseases.
[The White House] |
|
|
|
|
| October 12 – 13, 2023
Singapore & Virtual |
|
|
|
|
|
| | Cedars-Sinai – Los Angeles, California, United States |
|
|
|
| | Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| | Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| | Creative Biolabs – New York, New York, United States |
|
|
|
| | Center for Excellence in Molecular Cell Science – Shanghai, China |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
